Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,156.00
Bid: 12,124.00
Ask: 12,128.00
Change: -14.00 (-0.12%)
Spread: 4.00 (0.033%)
Open: 12,114.00
High: 12,258.00
Low: 12,114.00
Prev. Close: 12,170.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-European shares end week higher as Pfizer pill lifts travel stocks

Fri, 05th Nov 2021 10:12

* STOXX 600 marks fifth week of gains

* Pfizer COVID-19 pill turbo-charges travel stocks

* Allegro surges after Mall Group deal

* German, French stocks scale new peaks
(Adds comments, updates prices throughout)

By Shreyashi Sanyal

Nov 5 (Reuters) - European equities wrapped up another week
of gains on Friday, led by advances in travel stocks after a
positive update from U.S. drugmaker Pfizer on its pill for
COVID-19 and amid persistent optimism about earnings season.

The pan-European STOXX 600 ended flat, but clocked
1.7% in weekly gains, its fifth consecutive week in the green.

European travel stocks jumped 1.4% as investors
across the globe cheered Pfizer Inc's trial of an
experimental antiviral pill for COVID-19, which was shown to cut
risk of developing severe disease by 89%.

The news lifted shares of Swiss duty free retailer Dufry
by 10.1%, to its best day since November 9, 2020, while
also pushing down shares of AstraZeneca.

"Today's news out of the U.S. that Pfizer has developed a
COVID-19 pill, which is 89% effective in preventing
hospitalisation, may well be weighing on the AstraZeneca share
price a touch, but it has pretty much turbo-charged the airlines
and hospitality sector," said Michael Hewson, chief market
analyst at CMC Markets.

Dovish moves by the U.S. Federal Reserve and the Bank of
England, and similar comments from the European Central Bank
chief have helped sentiment this week.

Data from the U.S. Labor Department showed employment
increased more than expected in October as the headwinds from a
surge in COVID-19 infections over the summer subsided, also
supporting the day's upbeat mood.

On Friday, France's benchmark CAC 40 index breached
the 7,000 points barrier for the first time ever, and was up
0.8%.

The blue-chip index was led by gains in Kering,
Hermes and L'Oreal.

Germany's DAX reversed early declines to scale
fresh peaks, as investors shrugged off disappointing industrial
output data in Europe's biggest economy.

Gains in the STOXX 600 were led by Allegro, which
surged 10.6% after the Polish e-commerce group agreed to buy
Czech online retailer Mall Group for 881 million euros.

Spain's CaixaBank also rose 1.6% after saying it
had sold its entire 9.92% stake in Austrian bank Erste Group
for 1.503 billion euros. Erste added 5%.

A rebound in London-listed banks, which dropped after the
Bank of England's move on Thursday to hold rates, saw London's
FTSE 100 gain 0.3%.
(Reporting by Anisha Sircar, Susan Mathew and Shreyashi Sanyal
in Bengaluru; Editing by Shounak Dasgupta, William Maclean)

More News
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more
25 Apr 2024 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the first quarter.

Read more
25 Apr 2024 09:12

LONDON MARKET OPEN: Anglo American jumps on takeover bid from BHP

(Alliance News) - Stock prices in London opened mixed on Thursday, as investors cautiously eye data on the health of the US economy.

Read more
25 Apr 2024 08:38

AstraZeneca blows past analysts' estimates for Q1

(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.